13F-HR filed by Whitefort Capital Management, LP
Whitefort Capital Management, LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 18 holding rows worth $219,608,194.
- Accession
- 0001013594-24-000972
- Filer
- CIK 1884931
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 18 entries on the cover page, a total value of $219,608,194 stated on the cover page (in dollars after the unit check, H1), rows summing to $219,608,195 with VALUE read as dollars as filed, 13F file number 028-22014. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 12,867,967 | $49,541,673 | dollars as filed | |
| ENDEAVOR GROUP HLDGS INC | 29260Y109 | CL A COM | 1,000,000 | $28,560,000 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,391,000 | $27,592,140 | dollars as filed | |
| JOYY INC ADS REPSTG COM A | 46591M109 | ADR | 565,878 | $20,507,419 | dollars as filed | |
| GENWORTH FINL INC | 37247D106 | COM SHS | 2,986,960 | $20,460,676 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,702,025 | $17,020,250 | dollars as filed | |
| CORE SCIENTIFIC INC NEW | 21874A106 | COM | 1,147,500 | $13,609,350 | dollars as filed | |
| GLOBAL SHIP LEASE INC | Y27183600 | COM CL A | 366,771 | $9,774,447 | dollars as filed | |
| NEXTNAV INC | 65345N106 | COMMON STOCK | 1,252,831 | $9,383,704 | dollars as filed | |
| Esperion Therapeutics Inc | 29664WAB1 | NOTE 4.000%11/15/25 | 8,000,000 | $7,589,510 | dollars as filed | principal |
| SABRE GLBL INC | 78573NAE2 | BOND | 5,000,000 | $4,970,080 | dollars as filed | principal |
| INNOVATE CORP | 404139AG2 | NOTE 7.500% 8/0 | 12,218,000 | $4,096,085 | dollars as filed | principal |
| MAIDEN HOLDINGS LTD | G5753U112 | SHS | 2,048,163 | $3,625,249 | dollars as filed | |
| NEXTNAV INC | 65345N114 | *W EXP 99/99/999 | 482,951 | $1,400,558 | dollars as filed | |
| INNOVATE CORP | 45784J303 | COM NEW | 320,131 | $1,184,485 | dollars as filed | |
| OPKO HEALTH INC | 68375N103 | COM | 134,490 | $200,390 | dollars as filed | |
| TRINITY BIOTECH INVT LTD | 896438504 | SPONS ADR NEW | 81,902 | $90,092 | dollars as filed | |
| ALTENERGY ACQUISITION CORP | 02157M116 | *W EXP 10/29/202 | 186,315 | $2,087 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-24-000972 | this filing | 2024-11-14 | acceptance time not in the bulk data set |